Aino Rönkä
Senior Researcher
Institute of Clinical Medicine, School of Medicine, Faculty of Health Sciences
aino.ronka@uef.fi
Publications
10/10 items-
Front-line and second-line treatment for mantle cell lymphoma in clinical practice: A multicenter retrospective analysis
Harmanen, Minna; Sorigue, Marc; Khan, Madiha; Prusila, Roosa; Klaavuniemi, Tuula; Kari, Esa; Jantunen, Esa; Sunela, Kaisa; Rajamaki, Aino; Alanne, Erika; Kuitunen, Hanne; Jukkola, Arja; Sancho, Juan-Manuel; Kuittinen, Outi; Ronka, Aino. 2024. European journal of haematology. [Epub ahead of print 25 April 2024]: 1-9 -
High Numbers of CD163+ Tumor-Associated Macrophages Predict Poor Prognosis in HER2+ Breast Cancer
Jääskeläinen, Minna M; Tumelius, Ritva; Hämäläinen, Kirsi; Rilla, Kirsi; Oikari, Sanna; Rönkä, Aino; Selander, Tuomas; Mannermaa, Arto; Tiainen, Satu; Auvinen, Päivi. 2024. Cancers. 16: -
A practical prognostic peripheral blood-based risk model for the evaluation of the likelihood of a response and survival of metastatic cancer patients treated with immune checkpoint inhibitors
Tiainen, Satu; Nurmela, Veera; Selander, Tuomas; Turunen, Patrik; Pasonen-Seppänen, Sanna; Kettunen, Tiia; Kuittinen, Outi; Auvinen, Päivi; Rönkä, Aino. 2023. Bmc cancer. 23: . 1186 -
The prognostic and predictive role of tumor-infiltrating lymphocytes (FoxP3 + and CD8 +) and tumor-associated macrophages in early HER2 + breast cancer
Jääskeläinen, Minna M; Tiainen, Satu; Siiskonen, Hanna; Ahtiainen, Maarit; Kuopio, Teijo; Rönkä, Aino; Kettunen, Tiia; Hämäläinen, Kirsi; Rilla, Kirsi; Harvima, Ilkka; Mannermaa, Arto; Auvinen, Päivi. 2023. Breast cancer research and treatment. 201: 183-192 -
Survival of patients with mantle cell lymphoma in the rituximab era: Retrospective binational analysis between 2000 and 2020
Harmanen, Minna; Hujo, Mika; Sund, Reijo; Sorigue, Marc; Khan, Madiha; Prusila, Roosa; Klaavuniemi, Tuula; Kari, Esa; Jantunen, Esa; Sunela, Kaisa; Rajamäki, Aino; Alanne, Erika; Kuitunen, Hanne; Sancho, Juan‐Manuel; Jukkola, Arja; Rönkä, Aino; Kuittinen, Outi. 2022. British journal of haematology. 2023; 201: 64-74 -
Human memory CD4+ T cell response to the major dog allergen Can f 5, prostatic kallikrein
Kailaanmäki A, Kinnunen T, Rönkä A, Rytkönen-Nissinen M, Lidholm J,Mattsson L, Randell J, Virtanen T. 2016. Clinical and experimental allergy. 46: 720-729 -
Characterization of human memory CD4+ T-cell responses to the dog allergen Can f 4
Rönkä Aino L, Kinnunen Tuure T, Goudet Amélie, Rytkönen-Nissinen Marja A, Sairanen Joni, Kailaanmäki Anssi HT, Randell Jukka T, Maillére Bernard, Virtanen Tuomas I. 2015. Journal of allergy and clinical immunology. 136: 1047-1054.e10 -
Human T cell Response to Dog Lipocalin Allergens: Prospects for Allergen Immunotherapy
Rönkä Aino. 2015. Publications of the University of Eastern Finland. Dissertations in Health Sciences -
Mammal-Derived Respiratory Lipocalin Allergens do not Exhibit Dendritic Cell-Activating Capacity
Parviainen S, Kinnunen T, Rytkönen-Nissinen M, Nieminen A, Liukko A, Virtanen T. 2013. Scandinavian journal of immunology. 77: 171-176 -
Suboptimal recognition of a T cell epitope of the major dog allergen Can f 1 by human T cells
Juntunen R, Liukko A, Taivainen A, Närvänen A, Durand G, Kauppinen A, Nieminen A, Rytkönen-Nissinen M, Saarelainen S, Maillère B, Virtanen T, Kinnunen T. 2009. Molecular immunology. 46: 3320-3327